Provided by Tiger Trade Technology Pte. Ltd.

OPUS GENETICS INC

4.46
+0.05001.13%
Post-market: 4.570.1100+2.47%17:32 EDT
Volume:1.35M
Turnover:5.90M
Market Cap:371.05M
PE:-3.45
High:4.48
Open:4.41
Low:4.25
Close:4.41
52wk High:7.07
52wk Low:1.70
Shares:83.20M
Float Shares:64.45M
Volume Ratio:0.64
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2925
EPS(LYR):-0.8000
ROE:-4796.52%
ROA:-48.06%
PB:-28.57
PE(LYR):-5.57

Loading ...

JonesTrading Sticks to Their Buy Rating for Opus Genetics (IRD)

TIPRANKS
·
Jun 25

Opus Genetics Inc : RBC Initiates Coverage With Outperform Rating; Price Target $10

THOMSON REUTERS
·
Jun 23

Opus Genetics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Opus Genetics (IRD)

TIPRANKS
·
Jun 18

Opus Genetics assumed with a Buy at Chardan

TIPRANKS
·
Jun 18

Opus Genetics Price Target Maintained With a $12.00/Share by BTIG

Dow Jones
·
Jun 17

Opus Genetics hosts R&D Science Forum highlighting inherited retinal disease gene therapy pipeline

Reuters
·
Jun 17

Opus Genetics Price Target Maintained With a $11.00/Share by Citizens

Dow Jones
·
Jun 15

Opus Genetics - Files for Resale of up to 2.68 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jun 06

Opus Genetics Initiated at Buy by Guggenheim

Dow Jones
·
Jun 04

Guggenheim Initiates Opus Genetics at Buy With $16 Price Target

MT Newswires Live
·
Jun 04

Opus Genetics publishes investor presentation on gene therapy pipeline for rare inherited retinal diseases

Reuters
·
Jun 02

BRIEF-Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
May 29

Opus Genetics grants options for 698,000 shares to 10 new hires under inducement plan

Reuters
·
May 29

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 29

Opus Genetics presents at Jefferies Global Healthcare Conference

Reuters
·
May 27

Opus Genetics Initiated at Outperform by Leerink Partners

Dow Jones
·
May 21

Leerink Partners Initiates Opus Genetics at Outperform With $10 Price Target

MT Newswires Live
·
May 21

Opus Genetics initiated with an Outperform at Leerink

TIPRANKS
·
May 21

Opus Genetics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $10

THOMSON REUTERS
·
May 21